GH-RH antagonists inhibited the proliferative effects of IL-17, TGF-2, and macrophage-conditioned medium, indicating a key role of GH-RH in the inflammatory pathways 93
KLOW is studied in preclinical research on integrated tissue repair endpoints, multi-pathway inflammation research, and combined molecule pharmacology
L- ,
Current Areas of Scientific Investigation While there are not current studies evaluating the combination of methionine, choline, carnitine, and dexpanthenol, there are studies evaluating individual ingredients
Doses Studied in Clinical Trials Phase 2 trials have explored a wide range of weekly subcutaneous injections, with the following protocols tested: 1 mg per week Lowest dose, primarily studied for tolerability